[FG] Lang Undine

Dinsenbacher, Lisa L. et al. (2024) ‘Specialized short term crisis intervention for patients with personality disorder: Effects on coercion and length of stay’, International Journal of Social Psychiatry. 04.09.2024, 70(8), pp. 1516–1524. Available at: https://doi.org/10.1177/00207640241277161.

Huber, C.G., Wullschleger, A. and Rabenschlag, F. (2024) ‘Context-Sensitivity and the Inclusion of Subjective Beliefs Have Broad Implications’, The American Journal of Bioethics, 24(12), pp. 101–103. Available at: https://doi.org/10.1080/15265161.2024.2416140.

Köck, P. et al. (2024) ‘Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials’, Child and Adolescent Psychiatry and Mental Health, 18(1). Available at: https://doi.org/10.1186/s13034-024-00846-5.

Mosar, F. et al. (2024) ‘Lifestyle changes during first COVID-19 lockdown: A survey in patients on opioid agonist therapy and medical students in Switzerland’, Heroin Addiction and Related Clinical Problems, 26, pp. 1–10. Available at: https://doi.org/10.62401/2531-4122-2024-65.

Dechent, F. et al. (2024) ‘COVID-19 and mental distress among health professionals in eight European countries during the third wave: a cross-sectional survey’, Scientific Reports, 14(1). Available at: https://doi.org/10.1038/s41598-024-72396-x.

Liwinski, Timur et al. (2024) ‘Sustainability initiatives in inpatient psychiatry: tackling food waste’, Frontiers in Psychiatry, 15, pp. 1–14. Available at: https://doi.org/10.3389/fpsyt.2024.1374788.

Kreppke, Jan-Niklas et al. (2024) ‘Cardiorespiratory fitness, perceived fitness and autonomic function in in-patients with different depression severity compared with healthy controls’, Journal of Psychiatric Research, 175, pp. 437–445. Available at: https://doi.org/10.1016/j.jpsychires.2024.05.044.

Anna-Chiara Schaub et al. (2024) ‘Brain alterations in individuals with exercise dependence: A multimodal neuroimaging investigation’, Journal of Behavioral Addictions [Preprint]. Available at: https://doi.org/10.1556/2006.2024.00028.

Kreppke, Jan-Niklas et al. (2024) ‘Long-term outcomes of physical activity counseling in in-patients with major depressive disorder: results from the PACINPAT randomized controlled trial’, Translational Psychiatry, 14(1). Available at: https://doi.org/10.1038/s41398-024-02885-0.

Singh, Jasprit et al. (2024) ‘Implementation of a Budo group therapy for psychiatric in- and outpatients: a feasibility study’, Frontiers in Psychiatry, 15. Available at: https://doi.org/10.3389/fpsyt.2024.1338484.

Zullino, D. et al. (2024) ‘Addiction: what’s new in 2023 Addictions: ce qui a changé en 2023’, Revue Medicale Suisse, 20(856-7), pp. 12–14. Available at: https://doi.org/10.53738/revmed.2024.20.856-7.12.

Schwarz, T. et al. (2024) ‘Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland’, Drug and Alcohol Dependence, 254, p. 111036. Available at: https://doi.org/10.1016/j.drugalcdep.2023.111036.

Avrahami, M. et al. (2024) ‘Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis’, Psychopharmacology [Preprint]. Available at: https://doi.org/10.1007/s00213-024-06603-y.

Azar, Pouya et al. (2024) ‘Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder’, Addiction Science and Clinical Practice, 19. Available at: https://doi.org/10.1186/s13722-024-00479-1.

Bailey, Barbara et al. (2024) ‘Pathways to care in youth and young adults at clinical high risk for psychosis in Switzerland: Current situation and clinical implementation of the PsyYoung project’, Early Intervention in Psychiatry [Preprint]. Available at: https://doi.org/10.1111/eip.13540.

Baltes-Flueckiger, Lavinia et al. (2024) ‘How depression and ADHD relate to exercise addiction: a cross-sectional study among frequent exercisers’, Frontiers in Psychology, 15. Available at: https://doi.org/10.3389/fpsyg.2024.1427514.

Billian, Janina et al. (2024) ‘Patient-reported experience measures (PREMs) in outpatient psychiatry – is there an association to perceived discrimination and devaluation?’, Frontiers in Psychiatry, 15. Available at: https://doi.org/10.3389/fpsyt.2024.1378487.

Billian, Janina et al. (2024) ‘Treatment-seeking threshold and accessibility of psychiatric outpatient services in Switzerland: the relationship with stigma and self-esteem’, Frontiers in Psychiatry, 15. Available at: https://doi.org/10.3389/fpsyt.2024.1377971.

Brezan, Franciska et al. (2024) ‘Prolonged diacetylmorphine take-home during the COVID-19 pandemic—Results of a retrospective cohort study’, Addiction [Preprint]. Available at: https://doi.org/10.1111/add.16503.

Ferizaj, Drin et al. (2024) ‘Effectiveness of a mobile application for independent computerized cognitive training in patients with mild cognitive impairment: study protocol for the NeNaE Study, a randomized controlled trial’, Trials, 25. Available at: https://doi.org/10.1186/s13063-024-08277-5.

Fischer, A. et al. (2024) ‘Co-design of a voice-based app to monitor long COVID symptoms with its end-users: A mixed-method study’, Digital Health, 10. Available at: https://doi.org/10.1177/20552076241272671.

Gloster, Andrew T. et al. (2024) ‘When Average Isn’t Good Enough: Identifying Meaningful Subgroups in Clinical Data’, Cognitive Therapy and Research, 48, pp. 537–551. Available at: https://doi.org/10.1007/s10608-023-10453-x.

Hauser, Johannes et al. (2024) ‘Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety’, Frontiers in Psychiatry, 15. Available at: https://doi.org/10.3389/fpsyt.2024.1327598.

Heinz, Andreas et al. (2024) ‘Challenges in the treatment of opioid dependence’, Nervenarzt [Preprint]. Available at: https://doi.org/10.1007/s00115-024-01691-9.

Jaffé, Mariela E et al. (2024) ‘Just Not Enough: Utilization of Outpatient Psychotherapy Provided by Clinical Psychologists for Patients With Psychosis and Bipolar Disorder in Switzerland’, Health Services Insights, 17. Available at: https://doi.org/10.1177/11786329241229950.

Jaffé, Mariela et al. (2024) ‘Exploring correlates of high psychiatric inpatient utilization in Switzerland: A descriptive and machine learning analysis’, Psychiatry Research [Preprint].

Krückl, Jana S. et al. (2024) ‘Comparing the latent state–trait structure of the PANSS in cariprazine-medicated and placebo-controlled patients with acute schizophrenia’, European Archives of Psychiatry and Clinical Neuroscience [Preprint]. Available at: https://doi.org/10.1007/s00406-024-01790-3.

Liwinski, Timur, Huber, Christian G and Lang, Undine E (2024) ‘A milestone in patient-centred care’, The Lancet Psychiatry, null. Available at: https://doi.org/10.1016/s2215-0366(24)00062-2.

Mayer-Eckardt, Lennart N. et al. (2024) ‘Somatic and mental health among older patients in opioid agonist therapy: a cross-sectional geriatric assessment study’, Heroin Addiction and Related Clinical Problems, 26. Available at: https://doi.org/10.62401/2531-4122-2024-2.

Mosandl, Christoph Felix et al. (2024) ‘Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis’, Frontiers in Public Health, 12. Available at: https://doi.org/10.3389/fpubh.2024.1356988.

Singh, Jasprit et al. (2024) ‘Implementation of a Budo group therapy for psychiatric in- and outpatients: a feasibility study’, Frontiers in Psychiatry, 15. Available at: https://doi.org/10.3389/fpsyt.2024.1338484.

Thomann, Jan et al. (2024) ‘Development and validation of an LC-MS/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma’, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1237. Available at: https://doi.org/10.1016/j.jchromb.2024.124104.

van der Feltz-Cornelis, Christina M. et al. (2024) ‘Determinants of workload-related clinician stress levels in general hospital consultation liaison psychiatry services during the COVID-19 pandemic in England and Ireland. Short report’, Journal of Psychosomatic Research, 177. Available at: https://doi.org/10.1016/j.jpsychores.2023.111584.

Villanueva, Jeanette et al. (2024) ‘How mood is affected by environment and upsetting events: The moderating role of psychological flexibility’, Psychotherapy Research, 34, pp. 490–502. Available at: https://doi.org/10.1080/10503307.2023.2215392.

Benoy, C. et al. (2023) Akzeptanz- und Commitment-Therapie (ACT). 1 edn. Edited by Günter H. Seidler;Rita Rosner;Carsten Spitzer;Rolf-Dieter Stieglitz;Bernhard Strauß;Nina Heinrichs. Stuttgart: W. Kohlhammer GmbH. Available at: https://doi.org/10.17433/978-3-17-041792-2.

Fadakar, H. et al. (2023) ‘Suicidality among university students in the Eastern Mediterranean region: A systematic review’, PLOS Global Public Health, 3(10 October), p. e0002460. Available at: https://doi.org/10.1371/journal.pgph.0002460.

Kim JJ et al. (2023) ‘Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial.’, Drug and alcohol dependence, 249, p. 110874. Available at: https://doi.org/10.1016/j.drugalcdep.2023.110874.

Krausz RM et al. (2023) ‘A Call for an Evidence-Based Strategy Against the Overdose Crisis.’, Canadian journal of psychiatry. Revue canadienne de psychiatrie, p. 7067437231188202. Available at: https://doi.org/10.1177/07067437231188202.

Lang, U. (2023) Resilienz. 2 edn., Ressourcen stärken, psychisches Wohlbefinden steigern. 2 edn. Stuttgart: W. Kohlhammer GmbH (Ressourcen stärken, psychisches Wohlbefinden steigern). Available at: https://doi.org/10.17433/978-3-17-041187-6.

Müller, M. et al. (2023) ‘Cannabis Consumers” View of Regulated Access to Recreational Cannabis: A Multisite Survey in Switzerland’, European Addiction Research, 29(3), pp. 213–221. Available at: https://doi.org/10.1159/000530194.

Gerber, Markus et al. (2023) ‘Cardiorespiratory fitness and cardiovascular risk among in-patients with depression compared to healthy controls’, Frontiers in Psychiatry, 14. Available at: https://doi.org/10.3389/fpsyt.2023.1193004.

Gerber, Markus et al. (2023) ‘Differences in Selective Attention and Inhibitory Control in Patients with Major Depressive Disorder and Healthy Controls Who Do Not Engage in Sufficient Physical Activity’, Journal of Clinical Medicine, 12(10), p. 3370. Available at: https://doi.org/10.3390/jcm12103370.

Cody, Robyn et al. (2023) ‘An implementation evaluation of the physical activity counseling for in-patients with major depressive disorder (PACINPAT) intervention: a randomized controlled trial’, BMC Psychiatry, 23(1). Available at: https://doi.org/10.1186/s12888-023-04834-5.

Gloster AT et al. (2023) ‘Is helping you helping me? The assessment of helping others using event sampling methodology in a clinical and a non-clinical sample.’, The British journal of social psychology, 62(2), pp. 768–781. Available at: https://doi.org/10.1111/bjso.12593.

Solmi M et al. (2023) ‘Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults’, Journal of Affective Disorders, 326, pp. 249–261. Available at: https://doi.org/10.1016/j.jad.2022.12.022.

Traynor JM et al. (2023) ‘Dimensional personality impairment is associated with disruptions in intrinsic intralimbic functional connectivity’, Psychological Medicine, 53(4), pp. 1323–1333. Available at: https://doi.org/10.1017/S0033291721002865.

Westenberg JN et al. (2023) ‘Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study.’, Addiction science & clinical practice, 18(1), p. 15. Available at: https://doi.org/10.1186/s13722-023-00367-0.

Meyer, M. et al. (2023) Adverse effects of opioids prescribed in opioid agonist treatment: a systematic review protocol. Center for Open Science. Available at: https://doi.org/10.31219/osf.io/h2nr6.

Azar P et al. (2023) ‘48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method.’, Journal of addiction medicine, 17(2), pp. 233–236. Available at: https://doi.org/10.1097/adm.0000000000001072.

Nikoo M et al. (2023) ‘Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial.’, Addiction (Abingdon, England), 118(2), pp. 284–294. Available at: https://doi.org/10.1111/add.16030.

Vogel M, Dürsteler KM and Dürsteler KM (2023) ‘Buprenorphine Induction: Just a Piece of the Puzzle.’, Journal of addiction medicine [Preprint]. Available at: https://doi.org/10.1097/adm.0000000000001144.

Dechent, F. et al. (2023) ‘COVID-19 and mental distress among health professionals: a cross-sectional survey over eight European countries during the third wave (Preprint)’. JMIR Publications Inc. Available at: https://doi.org/10.2196/preprints.46109.

Hummel, S. et al. (2023) ‘Longitudinal insights in psychosocial stress expressed by health care professionals during the COVID-19 pandemic – a mixed-method approach (Preprint)’. JMIR Publications Inc. Available at: https://doi.org/10.2196/preprints.45609.

Vogel M et al. (2023) ‘Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.’, Harm reduction journal, 20(1), p. 2. Available at: https://doi.org/10.1186/s12954-023-00731-y.

Argote, Mathilde et al. (2023) ‘Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals’, eClinicalMedicine, 64. Available at: https://doi.org/10.1016/j.eclinm.2023.102199.

Baltes-Flueckiger, Lavinia et al. (2023) ‘Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial’, Frontiers in Psychiatry, 14. Available at: https://doi.org/10.3389/fpsyt.2023.1139325.

Cody, Robyn et al. (2023) ‘Short-term outcomes of physical activity counseling in in-patients with Major Depressive Disorder: Results from the PACINPAT randomized controlled trial’, Frontiers in Psychiatry, 13. Available at: https://doi.org/10.3389/fpsyt.2022.1045158.

Conchon, Caroline et al. (2023) ‘Improving Pathways to Care for Patients at High Psychosis Risk in Switzerland: PsyYoung Study Protocol’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12144642.

Fischer, A. et al. (2023) ‘Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study’, JMIR Research Protocols, 12. Available at: https://doi.org/10.2196/46103.

Gloster, Andrew T. et al. (2023) ‘Psychotherapy for Chronic In- and Outpatients with Common Mental Disorders: The ‘choose Change’ Effectiveness Trial’, Psychotherapy and Psychosomatics, 92, pp. 124–132. Available at: https://doi.org/10.1159/000529411.

Gómez Bravo, Raquel et al. (2023) ‘The psychological syndrome associated with Long-COVID: A study protocol’, Frontiers in Epidemiology, 3. Available at: https://doi.org/10.3389/fepid.2023.1193369.

Hummel, Svenja et al. (2023) ‘Unmet Psychosocial Needs of Health Care Professionals in Europe During the COVID-19 Pandemic: Mixed Methods Approach’, JMIR Public Health and Surveillance, 9. Available at: https://doi.org/10.2196/45664.

Krückl, Jana S. et al. (2023) ‘The association between the admission to wards with open- vs. closed-door policy and the use of coercive measures’, Frontiers in Psychiatry, 14. Available at: https://doi.org/10.3389/fpsyt.2023.1268727.

Liwinski, Timur and Lang, Undine E. (2023) ‘Folate and Its Significance in Depressive Disorders and Suicidality: A Comprehensive Narrative Review’, Nutrients, 15. Available at: https://doi.org/10.3390/nu15173859.

Liwinski, Timur et al. (2023) ‘Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut–Brain Axis’, Biomedicines, 11. Available at: https://doi.org/10.3390/biomedicines11123128.

Mayer-Eckardt, L.N. et al. (2023) ‘Somatic and Mental Health Among Older Patients in Opioid Agonist Therapy: A Cross-Sectional Geriatric Assessment Study’, Heroin Addiction And Related Clinical Problems [Preprint]. Available at: https://doi.org/10.2139/ssrn.4428985.

Meyer, Maximilian et al. (2023) ‘Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study’, Addiction Science and Clinical Practice, 18. Available at: https://doi.org/10.1186/s13722-023-00397-8.

Meyer, Maximilian et al. (2023) ‘Sexual dysfunction prevalence, risk factors, and help-seeking behavior in opioid agonist treatment and general psychiatry: a cross-sectional study’, Frontiers in Psychiatry, 14. Available at: https://doi.org/10.3389/fpsyt.2023.1204236.

Meyer, Maximilian et al. (2023) ‘Shifting drug markets in North America - a global crisis in the making?’, International Journal of Mental Health Systems, 17. Available at: https://doi.org/10.1186/s13033-023-00601-x.

Meyer M., Westenberg J.N. and Krausz R.M. (2023) ‘The Fentanyl System Shock – Are There Lessons to Learn From the COVID-19 System Shock Framework? Comment on “The COVID-19 System Shock Framework: Capturing Health System Innovation During the COVID-19 Pandemic”’, International Journal of Health Policy and Management, 12(1). Available at: https://doi.org/10.34172/ijhpm.2023.7409.

Sarlon, J., Partonen, T. and Lang, U.E. (2023) ‘Potential links between brown adipose tissue, circadian dysregulation, and suicide risk’, Frontiers in Neuroscience, 17. Available at: https://doi.org/10.3389/fnins.2023.1196029.

Schaefert, Rainer et al. (2023) ‘COVID-19-related consultation-liaison (CL) mental health services in general hospitals: A perspective from Europe and beyond’, Journal of Psychosomatic Research, 167. Available at: https://doi.org/10.1016/j.jpsychores.2023.111183.

Schaub, Anna-Chiara et al. (2023) ‘Transdiagnostic brain correlates of self-reported trait impulsivity: A dimensional structure-symptom investigation’, NeuroImage: Clinical, 38. Available at: https://doi.org/10.1016/j.nicl.2023.103423.

Schneider, Else et al. (2023) ‘Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial’, Journal of Psychiatry and Neuroscience, 48, pp. E23–E33. Available at: https://doi.org/10.1503/jpn.220117.

Schneider, Michael et al. (2023) ‘Compulsory psychiatric admissions in the canton of Basel-Stadt between September 2013 and April 2022: Analysis of the cantonal database of the Health Department of Basel-Stadt’, International Journal of Social Psychiatry, 69, pp. 865–874. Available at: https://doi.org/10.1177/00207640221141020.

Shams, F. et al. (2023) ‘Adherence to e-health interventions for substance use and the factors influencing it: Systematic Review, meta-analysis, and meta-regression’, Digital Health, 9. Available at: https://doi.org/10.1177/20552076231203876.

Steiger, Sahar et al. (2023) ‘General and Case-Specific Approval of Coercion in Psychiatry in the Public Opinion’, International Journal of Environmental Research and Public Health, 20. Available at: https://doi.org/10.3390/ijerph20032081.

Yamanbaeva, Gulnara et al. (2023) ‘Effects of a probiotic add-on treatment on fronto-limbic brain structure, function, and perfusion in depression: Secondary neuroimaging findings of a randomized controlled trial’, Journal of Affective Disorders, 324, pp. 529–538. Available at: https://doi.org/10.1016/j.jad.2022.12.142.

Ziltener, Tiziana et al. (2023) ‘Therapeutic leave and direct inpatient healthcare costs in inpatients with mental illness’, Journal of Psychiatric Research, 162, pp. 187–192. Available at: https://doi.org/10.1016/j.jpsychires.2023.05.023.

Caroline Macina et al. (2023) ‘Evaluating the psychometric properties of the German Self and Interpersonal Functioning Scale (SIFS)’, Journal of Personality Assessment [Preprint].

Mosandl C.F. et al. (2023) ‘Depressivität prädiktiv für Cannabiskonsummuster? - Erste Daten der Basler ‘WeedCare’-Studie zum regulierten Cannabisverkauf zu Genusszwecken’, Suchtmedizin - Addiction Medicine, 4(25), pp. 1–7.

Patrick Köck et al. (2023) ‘Komorbiditäten bei Jugendlichen im Transitionsalter mit Substanzkonsumstörungen – ein Überblick’, Schweizer Zeitschrift für Psychiatrie + Neurologie [Preprint].

Tai A.M.Y. et al. (2023) ‘Exploring the potential and limitations of ChatGPT for academic peer-reviewed writing: Addressing linguistic injustice and ethical concerns’, Journal of Academic Language & Learning. 24.07.2023, 1(17), p. 15. Available at: https://journal.aall.org.au/index.php/jall/article/view/903.

Tschopp A et al. (2023) ‘Exercise addiction and major depressive disorder – clinical diagnosesand longitudinal course’, Addiction and Health, 2(15), p. 144. Available at: https://doi.org/10.34172/ahj.2023.1404.

Dechent F, Moeller J and Huber CG (2022) ‘Meaning Analysis and Alienation: A Method of Immanent Critique in Acute Psychiatry.’, International journal of environmental research and public health, 19(23). Available at: https://doi.org/10.3390/ijerph192316194.

Vasilescu AN et al. (2022) ‘Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential.’, The international journal of neuropsychopharmacology, 25(11), pp. 946–950. Available at: https://doi.org/10.1093/ijnp/pyac051.

Wrege JS et al. (2022) ‘Attentional salience and the neural substrates of response inhibition in borderline personality disorder’, Psychological Medicine, 52(15), pp. 3451–3459. Available at: https://doi.org/10.1017/S0033291721000118.

Cody, R. et al. (2022) ‘An implementation evaluation of the physical activity counseling in in-patients with major depressive disorder (PACINPAT) randomized controlled trial’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-1935587/v1.

Krausz RM et al. (2022) ‘The upcoming synthetic ultrapotent opioid wave as a foreseeable disaster.’, 9(9). Available at: https://doi.org/10.1016/s2215-0366(22)00241-3.

Schumacher F et al. (2022) ‘Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice.’, The Journal of biological chemistry, 298(8), p. 102185. Available at: https://doi.org/10.1016/j.jbc.2022.102185.

Köck P et al. (2022) ‘A systematic literature review of clinical trials and therapeutic applications of ibogaine.’, Journal of substance abuse treatment, 138, p. 108717. Available at: https://doi.org/10.1016/j.jsat.2021.108717.

Meyer M et al. (2022) ‘Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment.’, Harm reduction journal, 19(1), p. 63. Available at: https://doi.org/10.1186/s12954-022-00644-2.

Schneeberger AR and Huber CG (2022) ‘Crisis within a crisis - the fragility of acute psychiatric care delivery.’, World psychiatry : official journal of the World Psychiatric Association (WPA), 21(2), pp. 245–246. Available at: https://doi.org/10.1002/wps.20969.

Krausz M et al. (2022) ‘Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth.’, Medicina (Kaunas, Lithuania), 58(4). Available at: https://doi.org/10.3390/medicina58040539.

Colledge F and Meyer M (2022) ‘Exercise Addiction - Status, Identification and Treatment.’, Praxis, 111(6), pp. 317–321. Available at: https://doi.org/10.1024/1661-8157/a003875.

Sarlon J et al. (2022) ‘Effectiveness of a Mindfulness-Based Mobile Application for the Treatment of Depression in Ambulatory Care: Protocol for a Randomized Controlled Trial.’, JMIR research protocols, 11(3), p. e33423. Available at: https://doi.org/10.2196/33423.

Meyer M et al. (2022) ‘Exploring why patients in heroin-assisted treatment are getting incarcerated-a qualitative study.’, BMC psychiatry, 22(1), p. 169. Available at: https://doi.org/10.1186/s12888-022-03814-5.

Lötscher F et al. (2022) ‘[How to deal with alcohol: a qualitative evaluation of 30 interviews with alcohol-dependent patients].’, Fortschritte der Neurologie-Psychiatrie, 90(3), pp. 93–99. Available at: https://doi.org/10.1055/a-1389-5641.

Meyer M et al. (2022) ‘Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic-Is an update of legal restrictions warranted?’, The International journal on drug policy, 101, p. 103548. Available at: https://doi.org/10.1016/j.drugpo.2021.103548.

Westenberg JN et al. (2022) ‘Treatment approaches and outcome trajectories for youth with high-risk opioid use: A narrative review’, Early Intervention in Psychiatry, 16(3), pp. 207–220. Available at: https://doi.org/10.1111/eip.13155.